US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 3.720
  • -0.050-1.33%
Close Apr 23 16:00 ET
  • 3.810
  • +0.090+2.42%
Post 18:03 ET
286.15MMarket Cap-2089P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
195.26%25.15M
0.17%28.1M
-59.77%5.9M
Operating revenue
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
195.26%25.15M
0.17%28.1M
-59.77%5.9M
Cost of revenue
Gross profit
Operating expense
23.53%243.01M
21.98%70.57M
31.45%60.94M
19.20%56.59M
21.95%54.91M
22.64%196.72M
26.62%57.85M
7.33%46.36M
25.42%47.48M
33.74%45.03M
Selling and administrative expenses
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
-11.73%14.64M
20.71%15.14M
35.40%15.04M
-General and administrative expense
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
-11.73%14.64M
20.71%15.14M
35.40%15.04M
Research and development costs
31.53%180.43M
24.64%53.77M
44.00%45.67M
28.64%41.59M
31.37%39.4M
31.39%137.17M
44.13%43.14M
19.22%31.71M
27.75%32.33M
32.92%29.99M
Operating profit
30.76%-89.28M
187.67%43.15M
-107.52%-44.01M
-138.29%-46.18M
-7.93%-42.24M
-30.87%-128.94M
-40.49%-49.22M
38.83%-21.21M
-97.64%-19.38M
-105.86%-39.13M
Net non-operating interest income expense
-8,577.06%-9.24M
-247.96%-4.17M
-132.53%-4.13M
-29.72%-515K
21.26%-426K
104.26%109K
646.71%2.82M
-149.51%-1.77M
40.92%-397K
18.15%-541K
Non-operating interest income
319.97%14.51M
114.19%4.56M
348.72%4.55M
1,342.64%2.84M
2,106.90%2.56M
498.79%3.46M
2,116.67%2.13M
830.28%1.01M
12.57%197K
-41.12%116K
Non-operating interest expense
609.80%23.75M
1,360.03%8.73M
211.15%8.68M
465.15%3.36M
354.49%2.99M
6.66%3.35M
-213.24%-693K
240.00%2.79M
-29.87%594K
-23.43%657K
Other net income (expense)
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
-22.02%3.5M
-186.38%-3.74M
105.27%563K
Gain on sale of security
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
-22.02%3.5M
-186.38%-3.74M
105.27%563K
Income before tax
24.08%-88.6M
235.49%46.87M
-143.46%-47.45M
-63.21%-38.37M
-26.96%-49.66M
-10.58%-116.7M
9.26%-34.59M
36.94%-19.49M
-282.18%-23.51M
-28.83%-39.11M
Income tax
627.68%18.19M
15.81M
1.84M
-93.96%151K
395K
2.5M
0
0
2.5M
0
Net income
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
-28.83%-39.11M
Net income continuous Operations
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
-28.83%-39.11M
Minority interest income
Net income attributable to the parent company
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
-28.83%-39.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
-28.83%-39.11M
Basic earnings per share
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
44.78%-0.37
-323.08%-0.55
-27.27%-0.84
Diluted earnings per share
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
44.78%-0.37
-323.08%-0.55
-27.27%-0.84
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M195.26%25.15M0.17%28.1M-59.77%5.9M
Operating revenue 126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M195.26%25.15M0.17%28.1M-59.77%5.9M
Cost of revenue
Gross profit
Operating expense 23.53%243.01M21.98%70.57M31.45%60.94M19.20%56.59M21.95%54.91M22.64%196.72M26.62%57.85M7.33%46.36M25.42%47.48M33.74%45.03M
Selling and administrative expenses 5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M-11.73%14.64M20.71%15.14M35.40%15.04M
-General and administrative expense 5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M-11.73%14.64M20.71%15.14M35.40%15.04M
Research and development costs 31.53%180.43M24.64%53.77M44.00%45.67M28.64%41.59M31.37%39.4M31.39%137.17M44.13%43.14M19.22%31.71M27.75%32.33M32.92%29.99M
Operating profit 30.76%-89.28M187.67%43.15M-107.52%-44.01M-138.29%-46.18M-7.93%-42.24M-30.87%-128.94M-40.49%-49.22M38.83%-21.21M-97.64%-19.38M-105.86%-39.13M
Net non-operating interest income expense -8,577.06%-9.24M-247.96%-4.17M-132.53%-4.13M-29.72%-515K21.26%-426K104.26%109K646.71%2.82M-149.51%-1.77M40.92%-397K18.15%-541K
Non-operating interest income 319.97%14.51M114.19%4.56M348.72%4.55M1,342.64%2.84M2,106.90%2.56M498.79%3.46M2,116.67%2.13M830.28%1.01M12.57%197K-41.12%116K
Non-operating interest expense 609.80%23.75M1,360.03%8.73M211.15%8.68M465.15%3.36M354.49%2.99M6.66%3.35M-213.24%-693K240.00%2.79M-29.87%594K-23.43%657K
Other net income (expense) -18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M-22.02%3.5M-186.38%-3.74M105.27%563K
Gain on sale of security -18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M-22.02%3.5M-186.38%-3.74M105.27%563K
Income before tax 24.08%-88.6M235.49%46.87M-143.46%-47.45M-63.21%-38.37M-26.96%-49.66M-10.58%-116.7M9.26%-34.59M36.94%-19.49M-282.18%-23.51M-28.83%-39.11M
Income tax 627.68%18.19M15.81M1.84M-93.96%151K395K2.5M002.5M0
Net income 10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M-28.83%-39.11M
Net income continuous Operations 10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M-28.83%-39.11M
Minority interest income
Net income attributable to the parent company 10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M-28.83%-39.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M-28.83%-39.11M
Basic earnings per share 24.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.6144.78%-0.37-323.08%-0.55-27.27%-0.84
Diluted earnings per share 24.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.6144.78%-0.37-323.08%-0.55-27.27%-0.84
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg